Introduction
Purified ethanolic solutions of 05% podophyllotoxin have in recent years been available for self-treatment of external genital warts in both male'-3 and female patients. 45 The 0 5% cream formulation of podophyllotoxin was developed in order to make application more convenient with an efficacy-safety profile comparable to that of podophyllotoxin solution 0O5%. The use of a solution and applicator is convenient in the self-treatment of warts Patients who had been given a diagnosis of condyloma acuminatum were enrolled if they were in general good health and if they had not received topical or systemic antiviral or antiwart therapy within the last four weeks.
Clinical efficacy was determined by quantitative assessment of the treated warts. The two larger perpendicular dimensions of the warts were measured and the wart area was defined as the product of those two measurements. Clearing of warts were defined as the disappearance of all treated warts in a patient.
Safety was assessed by questioning and examining patients for local reactions indicating intolerance of the treatment. Adverse reactions including tenderness, burning, pain, erythema, erosions and oedema were noticed and if present described as mild, moderate or severe.
The distributions of the demographic and efficacy and safety data on the two treatment groups were compared with the use of analyses of variance, the Wilcoxon test, Fisher's exact test and the chi square test.
Results

Clinical efficacy
The demographic data of included patients are shown in table 1. The majority of treated wart lesions were penile and the mean wart area was comparable in the two treatment groups. Application of podophyllotoxin solution 0.5% was associated with a rapid and significant 
